Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 16830

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.


Publication type: Electronic Source

Silverman E
UK Charges Former J&J Exec With Corruption
Pharmalot 2009 Dec 1

Full text:

Robert John Dougall, 44, a former vice president for market development at J&J’s DePuy unit, was charged in connection with payments made or inducements given to medical professionals working in the Greek public health care system between 2002 and 2005, according to the UK Serious Fraud Office. The investigation remains ongoing and no further details were provided.
Two years ago, Johnson & Johnson disclosed that unspecified foreign subsidiaries may have made improper payments in some unnamed countries related to the sale of medical devices. And J&J acknowledged the payments may fall within the jurisdiction of the Foreign Corrupt Practices Act. So the Department of Justice and the Securities and Exchange Commission were notified. Michael Dormer, the global head of devices and diagnostics, retired at the time of the disclosure (background).
You may recall that, last month, the head of the Justice Department’s Criminal Division warned the pharmaceutical industry that there will be more criminal enforcement against interactions with foreign officials (read more here).


  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Click to Register

(read more)

Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts

If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend